The ribosome inhibitor chloramphenicol induces motility deficits in human spermatozoa: A proteomic approach identifies potentially involved proteins
Mature spermatozoa are almost completely devoid of cytoplasm; as such it has long been believed that they do not contain ribosomes and are therefore not capable of synthesising proteins. However, since the 1950s, various studies have shown translational activity within spermatozoa, particularly duri...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2022.965076/full |
_version_ | 1828136932825104384 |
---|---|
author | Marie Bisconti Baptiste Leroy Meurig T. Gallagher Coralie Senet Baptiste Martinet Vanessa Arcolia Ruddy Wattiez Jackson C. Kirkman-Brown Jean-François Simon Elise Hennebert |
author_facet | Marie Bisconti Baptiste Leroy Meurig T. Gallagher Coralie Senet Baptiste Martinet Vanessa Arcolia Ruddy Wattiez Jackson C. Kirkman-Brown Jean-François Simon Elise Hennebert |
author_sort | Marie Bisconti |
collection | DOAJ |
description | Mature spermatozoa are almost completely devoid of cytoplasm; as such it has long been believed that they do not contain ribosomes and are therefore not capable of synthesising proteins. However, since the 1950s, various studies have shown translational activity within spermatozoa, particularly during their in vitro capacitation. But the type of ribosomes involved (cytoplasmic or mitochondrial) is still debated. Here, we investigate the presence and activity of the two types of ribosomes in mature human spermatozoa. By targeting ribosomal RNAs and proteins, we show that both types of ribosomes are localized in the midpiece as well as in the neck and the base of the head of the spermatozoa. We assessed the impact of cycloheximide (CHX) and chloramphenicol (CP), inhibitors of cytoplasmic and mitochondrial ribosomes, respectively, on different sperm parameters. Neither CHX, nor CP impacted sperm vitality, mitochondrial activity (measured through the ATP content), or capacitation (measured through the content in phosphotyrosines). However, increasing CP concentrations induced a decrease in total and progressive motilities as well as on some kinematic parameters while no effect was observed with CHX. A quantitative proteomic analysis was performed by mass spectrometry in SWATH mode to compare the proteomes of spermatozoa capacitated in the absence or presence of the two ribosome inhibitors. Among the ∼700 proteins identified in the different tested conditions, 3, 3 and 25 proteins presented a modified abundance in the presence of 1 and 2 mg/ml of CHX, and 1 mg/ml of CP, respectively. The observed abundance variations of some CP-down regulated proteins were validated using Multiple-Reaction Monitoring (MRM). Taken together, our results are in favor of an activity of mitochondrial ribosomes. Their inhibition by CP results in a decrease in the abundance of several proteins, at least FUNDC2 and QRICH2, and consequently induces sperm motility deficits. |
first_indexed | 2024-04-11T18:12:47Z |
format | Article |
id | doaj.art-2e11178de0ae4aa88a86efecc5cfeded |
institution | Directory Open Access Journal |
issn | 2296-634X |
language | English |
last_indexed | 2024-04-11T18:12:47Z |
publishDate | 2022-09-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Cell and Developmental Biology |
spelling | doaj.art-2e11178de0ae4aa88a86efecc5cfeded2022-12-22T04:10:04ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2022-09-011010.3389/fcell.2022.965076965076The ribosome inhibitor chloramphenicol induces motility deficits in human spermatozoa: A proteomic approach identifies potentially involved proteinsMarie Bisconti0Baptiste Leroy1Meurig T. Gallagher2Coralie Senet3Baptiste Martinet4Vanessa Arcolia5Ruddy Wattiez6Jackson C. Kirkman-Brown7Jean-François Simon8Elise Hennebert9Laboratory of Cell Biology, Research Institute for Biosciences, Research Institute for Health Sciences and Technology, University of Mons, Mons, BelgiumLaboratory of Proteomics and Microbiology, CISMa, Research Institute for Biosciences, University of Mons, Mons, BelgiumCentre for Systems Modelling and Quantitative Biomedicine, University of Birmingham, Centre for Human Reproductive Science, Birmingham Women’s and Children’s National Health Service Foundation Trust, Birmingham, United KingdomLaboratory of Cell Biology, Research Institute for Biosciences, Research Institute for Health Sciences and Technology, University of Mons, Mons, BelgiumEvolutionary Biology and Ecology, Université Libre de Bruxelles, Brussels, BelgiumClinique de Fertilité Régionale de Mons, CHU Ambroise Paré Hospital, Mons, BelgiumLaboratory of Proteomics and Microbiology, CISMa, Research Institute for Biosciences, University of Mons, Mons, BelgiumInstitute of Metabolism and Systems Research, University of Birmingham, Centre for Human Reproductive Science, Birmingham Women’s and Children’s National Health Service Foundation Trust, Birmingham, United KingdomClinique de Fertilité Régionale de Mons, CHU Ambroise Paré Hospital, Mons, BelgiumLaboratory of Cell Biology, Research Institute for Biosciences, Research Institute for Health Sciences and Technology, University of Mons, Mons, BelgiumMature spermatozoa are almost completely devoid of cytoplasm; as such it has long been believed that they do not contain ribosomes and are therefore not capable of synthesising proteins. However, since the 1950s, various studies have shown translational activity within spermatozoa, particularly during their in vitro capacitation. But the type of ribosomes involved (cytoplasmic or mitochondrial) is still debated. Here, we investigate the presence and activity of the two types of ribosomes in mature human spermatozoa. By targeting ribosomal RNAs and proteins, we show that both types of ribosomes are localized in the midpiece as well as in the neck and the base of the head of the spermatozoa. We assessed the impact of cycloheximide (CHX) and chloramphenicol (CP), inhibitors of cytoplasmic and mitochondrial ribosomes, respectively, on different sperm parameters. Neither CHX, nor CP impacted sperm vitality, mitochondrial activity (measured through the ATP content), or capacitation (measured through the content in phosphotyrosines). However, increasing CP concentrations induced a decrease in total and progressive motilities as well as on some kinematic parameters while no effect was observed with CHX. A quantitative proteomic analysis was performed by mass spectrometry in SWATH mode to compare the proteomes of spermatozoa capacitated in the absence or presence of the two ribosome inhibitors. Among the ∼700 proteins identified in the different tested conditions, 3, 3 and 25 proteins presented a modified abundance in the presence of 1 and 2 mg/ml of CHX, and 1 mg/ml of CP, respectively. The observed abundance variations of some CP-down regulated proteins were validated using Multiple-Reaction Monitoring (MRM). Taken together, our results are in favor of an activity of mitochondrial ribosomes. Their inhibition by CP results in a decrease in the abundance of several proteins, at least FUNDC2 and QRICH2, and consequently induces sperm motility deficits.https://www.frontiersin.org/articles/10.3389/fcell.2022.965076/fullhuman spermatozoacapacitationribosomecycloheximidechoramphenicolsperm parameters |
spellingShingle | Marie Bisconti Baptiste Leroy Meurig T. Gallagher Coralie Senet Baptiste Martinet Vanessa Arcolia Ruddy Wattiez Jackson C. Kirkman-Brown Jean-François Simon Elise Hennebert The ribosome inhibitor chloramphenicol induces motility deficits in human spermatozoa: A proteomic approach identifies potentially involved proteins Frontiers in Cell and Developmental Biology human spermatozoa capacitation ribosome cycloheximide choramphenicol sperm parameters |
title | The ribosome inhibitor chloramphenicol induces motility deficits in human spermatozoa: A proteomic approach identifies potentially involved proteins |
title_full | The ribosome inhibitor chloramphenicol induces motility deficits in human spermatozoa: A proteomic approach identifies potentially involved proteins |
title_fullStr | The ribosome inhibitor chloramphenicol induces motility deficits in human spermatozoa: A proteomic approach identifies potentially involved proteins |
title_full_unstemmed | The ribosome inhibitor chloramphenicol induces motility deficits in human spermatozoa: A proteomic approach identifies potentially involved proteins |
title_short | The ribosome inhibitor chloramphenicol induces motility deficits in human spermatozoa: A proteomic approach identifies potentially involved proteins |
title_sort | ribosome inhibitor chloramphenicol induces motility deficits in human spermatozoa a proteomic approach identifies potentially involved proteins |
topic | human spermatozoa capacitation ribosome cycloheximide choramphenicol sperm parameters |
url | https://www.frontiersin.org/articles/10.3389/fcell.2022.965076/full |
work_keys_str_mv | AT mariebisconti theribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins AT baptisteleroy theribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins AT meurigtgallagher theribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins AT coraliesenet theribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins AT baptistemartinet theribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins AT vanessaarcolia theribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins AT ruddywattiez theribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins AT jacksonckirkmanbrown theribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins AT jeanfrancoissimon theribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins AT elisehennebert theribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins AT mariebisconti ribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins AT baptisteleroy ribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins AT meurigtgallagher ribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins AT coraliesenet ribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins AT baptistemartinet ribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins AT vanessaarcolia ribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins AT ruddywattiez ribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins AT jacksonckirkmanbrown ribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins AT jeanfrancoissimon ribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins AT elisehennebert ribosomeinhibitorchloramphenicolinducesmotilitydeficitsinhumanspermatozoaaproteomicapproachidentifiespotentiallyinvolvedproteins |